logo
Wrong email address or username
Wrong email address or username
Incorrect verification code
back to top
Search tags: radiopharmaceuticals-market
Load new posts () and activity
Like Reblog Comment
text 2020-08-10 13:49
North American Global Nuclear Medicine/Radiopharmaceuticals Market | Application (Oncology, Cardiology)

Growth in the market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer & cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.

 

The North American nuclear medicine market is expected to reach USD 2.7 billion by 2024 from an estimated USD 2.2 billion in 2019, growing at a CAGR of 4.1% during the forecast period.

 

 

 

The growth of the market can be attributed to increasing drug discovery activities, the growing biopharmaceutical industry, and the rising trend in outsourcing compound/sample management. The rising drug discovery activity is leading to an increased demand for compounds, which is positively affecting market growth.

Based on type, the market is categorized into diagnostic and therapeutic nuclear medicine. The therapeutic nuclear medicine segment is further segmented into alpha emitters, beta emitters, and brachytherapy isotopes.

 

In 2013, the FDA approved the first and only product for alpha emitters in the market, launched by Bayer AG under the name Xofigo (a Ra-223 dichloride molecule). The North American market for Ra-223 is expected to command the largest share owing to its targeted properties over beta emitters and being the only alpha-emitter product available in the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1108

Global North American Nuclear Medicine/Radiopharmaceuticals Market is Segmented on:

1. Type
2. Therapeutic
3. Application

Based on application, the North American nuclear medicine market is segmented into SPECT, PET, and therapeutic applications. The SPECT applications segment is further segmented into cardiology, bone scans, thyroid applications, pulmonary scans, and other SPECT applications. The thyroid applications segment is projected to register the highest growth rate in the forecast period. The high growth of this segment can be attributed to the increasing incidence and prevalence of thyroid disorders.

The rising drug discovery activity, coupled with increasing pharmaceutical companies, is the major factor driving the growth of the segment.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1108

The geographical regions mapped in the report are:

Geographically, the North American market comprises of US and Canada. In 2018, the US accounted for the largest share of the nuclear medicine market. The large share can be attributed to the development of novel technologies for radioisotope production, government funding, and company initiatives in the country.

Some key players mentioned in the research report are:

Cardinal Health (US), GE Healthcare (US), Curium (France), Lantheus Medical Imaging (US), Bayer AG (Germany), Bracco Imaging (Italy), Eczacýbaþý-Monrol Nuclear Products (Turkey), Nordion (Canada), Advanced Accelerator Applications (France), and NTP Radioisotopes (South Africa).

Like Reblog Comment
text 2020-04-30 14:58
Nuclear Medicine or Radiopharmaceuticals Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2020 to 2027

Nuclear Medicine or Radiopharmaceuticals Market is estimated to value over USD 6.1 billion by 2027 end and register a CAGR of over 4.9% during the forecast period 2020 to 2027.

The report initiates from the outline of business surroundings and explains the commercial summary of chain structure. Moreover, it analyses forecast by product type, by application, by region and Nuclear Medicine or Radiopharmaceuticals Market Forecast.

Additionally, this report illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This report provides valuable insights on the general market profit through a profit graph, an in depth SWOT analysis of the market trends along side the regional proliferation of this business vertical.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3463&page=requestsample

 

Market Segmentation:

This Market is divided By Product Type, By Application and By Region.

Regionally, the worldwide Nuclear Medicine or Radiopharmaceuticals Market is fragmented as North America, Europe, Asia Pacific and also the rest of the world.

 

Key Market Players:

Major market players enclosed within this market are  Cardinal Health Inc. Lantheus Medical Imaging Inc., GE Healthcare,  Eczacibasi-Monrol Nuclear Products, IBA Molecular Imaging, Bayer Healthcare, Nordion Inc, Bracco Imaging S.p.A, Advanced Accelerator Applications S.A.

(Note: The list of the key players are going to be updated with the most recent market scenario and trends)

Purchase a Copy & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3463&page=askfordiscount

 

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points touching market growth

Competitive Landscape:

  • Tier 1 players- well-established companies in the market accounting a major market share  
  • Tier 2 players 
  • Rapidly growing players
  • New Entrants

 

Objectives of the Study:

  • To offer with an complete analysis on the Nuclear Medicine or Radiopharmaceuticals Market by product type, by application and by region.
  • To cater comprehensive data on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To measure and forecast micro-markets and also the overall market
  • To predict the market size, in key regions — North America, Europe, Asia Pacific and rest of the world
  • To record and evaluate the competitive landscape mapping - product launches, technological advancements, mergers and expansions

 

Browse Corresponding Healthcare Research Reports& Consulting

  • Flow Cytometers Market is forecasted to value over USD 7.1 billion by 2027 end and register a CAGR of 11% from the forecast period 2020-2027.
  • Face Mask for Anti-Pollution Market is forecasted to value over USD 5.6 billion by 2027 end and register a CAGR of 10.3% from the forecast period 2020-2027.

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

About FutureWise Research:

We specialize in high-growth niche market research, assuring flexibility, agility and customized solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

 

Company Name: FutureWise Research

Contact Person:  VinayThaploo

Email: sales@futurewiseresearch.com

Phone: +44 141 628 9353 / +1 347 709 4931

City:  Leeds

Country:  United Kingdom

Website: www.futurewiseresearch.com

Like Reblog Comment
text 2020-03-16 11:15
Nuclear Medicine or Radiopharmaceuticals Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market Forecast 2020 to 2027

Nuclear Medicine or Radiopharmaceuticals Market is estimated to value over USD 6.1 billion by 2027 end and register a CAGR of over 4.9% during the forecast period 2020 to 2027.

The report initiates from the outline of business surroundings and explains the commercial summary of chain structure. Moreover, it analyses Forecast By Type, By Application, By Procedural Volume, and By Region and Nuclear Medicine or Radiopharmaceuticals Market.

Additionally, this report illustrates the corporate profiles and situation of competitive landscape amongst numerous associated corporations including the analysis of market evaluation and options associated with the worth chain. This report provides valuable insights into the general market profit through a profit graph, an in-depth SWOT analysis of the market trends alongside the regional proliferation of this business vertical.

 

Request a Sample Report @https://www.futurewiseresearch.com/request-sample.aspx?id=3463&page=requestsample

 

Market Segmentation:

This Market is divided By Type, By Application, By Procedural Volume, and By Region

Regionally, the worldwide Nuclear Medicine or Radiopharmaceuticals Market is fragmented as North America, Europe, Asia Pacific and also the rest of the world.

 

Key Market Players:

Major market players enclosed within this market are:

Cardinal Health Inc. Lantheus Medical Imaging Inc., GE Healthcare,  Eczacibasi-Monrol Nuclear Products, IBA Molecular Imaging, Bayer Healthcare, Nordion Inc, Bracco Imaging S.p.A, Advanced Accelerator Applications S.A.

(Note: The list of the key players are going to be updated with the most recent market scenario and trends)

 

Purchase a Copy & Ask For Discount:https://www.futurewiseresearch.com/request-sample.aspx?id=3463&page=askfordiscount

 

FutureWise Key Takeaways:

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points touching market growth

 

Competitive Landscape:

  • Tier 1 players- well-established companies in the market accounting a major market share 
  • Tier 2 players
  • Rapidly growing players
  • New Entrants

 

Objectives of the Study:

  • To offer a complete analysis of the Nuclear Medicine or Radiopharmaceuticals Market By Type, By Application, By Procedural Volume, and By Region
  • To cater to comprehensive data on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To measure and forecast micro-markets and also the overall market
  • To predict the market size, in key regions — North America, Europe, Asia Pacific and Rest of the world
  • To record and evaluate the competitive landscape mapping - product launches, technological advancements, mergers and expansions

 

 

Browse Corresponding Healthcare Market Research Reports & Consulting      

  • Allergy Immunotherapy Market is forecasted to value over USD xx billion by 2027 end and register a CAGR of xx% from the forecast period 2020-2027. FutureWise Market Research has illustrated a report on the Allergy Immunotherapy Market. The report provides an in-depth anatomy of the market trends affecting its growth.
  • Automatic CPR Devices Market is forecasted to value over USD xx billion by 2027 end and register a CAGR of xx% from the forecast period 2020-2027. FutureWise Market Research has illustrated a report on the Automatic CPR Devices Market. The report provides an in-depth anatomy of the market trends affecting its growth.

 

 

Flexible Delivery Model:

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization services offered are free of charge with the purchase of any license of the report.
  • You can directly share your requirements/changes to the current table of content to sales@futurewiseresearch.com

 

About FutureWise Research:

We specialize in high-growth niche market research, assuring flexibility, agility and customized solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

 

Company Name: FutureWise Research

Contact Person: Vinay Thaploo

Email: sales@futurewiseresearch.com

Phone: +44 141 628 9353 / +1 347 709 4931

City: Leeds

Country: United Kingdom

Website: www.futurewiseresearch.com

Like Reblog Comment
text 2019-08-05 10:03
Global PET Radiopharmaceuticals Market Analysis 2019, Highlights Scope

5-aug-19 This report studies the global PET Radiopharmaceuticals market status and forecast, categorizes the global PET Radiopharmaceuticals market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).

The major manufacturers covered in this report 

  • Cardinal Health Inc. (U.S.)
  • Mallinckrodt plc (Ireland)
  • GE Healthcare (U.K.)
  • Lantheus Medical Imaging, Inc. (U.S.)
  • Bayer AG (Germany)
  • Bracco Imaging S.p.A (Italy)
  • Eczacibasi-Monrol Nuclear Products (Turkey)


Interested in this report? Get your FREE sample now! https://www.radiantinsights.com/research/global-pet-radiopharmaceuticals-market-research-report-2019/request-sample

Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering

  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India


We can also provide the customized separate regional or country-level reports, for the following regions:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia


On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

  • F-18
  • Ru-82
  • Others


On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including

  • Oncology
  • Cardiology
  • Neurology
  • Others


The study objectives of this report are:

  • To analyze and study the global PET Radiopharmaceuticals capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
  • Focuses on the key PET Radiopharmaceuticals manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.


In this study, the years considered to estimate the market size of PET Radiopharmaceuticals are as follows:

  • History Year: 2013-2017
  • Base Year: 2017
  • Estimated Year: 2018
  • Forecast Year 2018 to 2025


Read the in depth blog @ https://www.radiantinsights.com/research/global-pet-radiopharmaceuticals-market-research-report-2019

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

  • PET Radiopharmaceuticals Manufacturers
  • PET Radiopharmaceuticals Distributors/Traders/Wholesalers
  • PET Radiopharmaceuticals Subcomponent Manufacturers
  • Industry Association
  • Downstream Vendors



Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the PET Radiopharmaceuticals market, by end-use.
Detailed analysis and profiles of additional market players.

If you have any special requirements, please let us know and we will offer you the report as you want.

More posts
Your Dashboard view:
Need help?